[Physiopathology, diagnosis and management of bone metastases from prostate cancer] (Q82908399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

title

[Physiopathology, diagnosis and management of bone metastases from prostate cancer] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

T Lebret

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

A Méjean

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

volume

18 Suppl 7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

S349-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The effects of orchidectomy on skeletal metabolism in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Detection and isolation of prostate cancer cells from peripheral blood and bone marrow

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Dynamic process of prostate cancer metastasis to bone.

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

What is the role of serial bone mineral density measurements in patient management?

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Mortality and institutionalization following hip fracture

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Bone density and fracture risk in men.

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Biochemical markers and skeletal metastases

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Bone markers in the management of metastatic bone disease

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Serial Markers of Bone Turnover in Men with Metastatic Prostate Cancer Treated with Zoledronic Acid for Detection of Bone Metastases Progression

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone metastases chemotherapy monitoring in breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The if's, and's, or but's regarding bisphosphonates for prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Bone metastasis: pathogenesis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Bisphosphonates in the treatment of bone diseases

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Preclinical pharmacology of zoledronic acid

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

The Final Report of the Expert Panel for the Radiation Oncology Bone Metastasis Work Group of the American College of Radiology

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

External beam radiotherapy for painful osseous metastases: pooled data dose response analysis

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Strontium 89 therapy for the palliation of pain due to osseous metastases

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Radiation therapy and radio-nuclides for palliation of bone pain

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

Clinical development of anti-RANKL therapy

1 reference

https://api.crossref.org/works/10.1016/S1166-7087(08)74566-4

7 January 2021

10.1016/S1166-7087(08)74566-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070815 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference